Angelini Ventures

corporate vc$300MCo-investsLeads rounds

◆ Fund Size

$300M

◆ Check Size

$3.9M→$115.5M

◆ Location

Italy

◆ Portfolio

13 companies

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Investment Thesis

Financing for European biotechnology and digital health startups in partnership with the European Investment Bank.

◆ About Angelini Ventures

Angelini Ventures is the corporate venture capital arm of Angelini Industries, focusing on early-stage investments in biotechnology, digital health, and life sciences. With €300 million in capital commitments, the firm aims to leverage technology to improve healthcare, reshape patient journeys, and address unmet needs in vulnerable populations.

◆ Sectors

BiotechDigital Health

◆ Stages

seed

◆ Geography Focus

Europe

◆ Team

Name	Title	Role	Links
Elia Stupka	Managing Director	Managing Director	in
Gabriela Manrique	Partner	Partner	in
Paolo Di Giorgio	CEO and Managing Director	Managing Director	in
Regina Hodits	Managing Director	Managing Director	in
Tanja Dowe	Managing Director	Managing Director	in

◆ Tracked Investments

Aptadir Therapeutics

◆ Notable Investments

Pretzel TherapeuticsArgobioSerenisNouscomEpicrisprHandspring HealthNuclidiumLaigo BioCoMindAdcytherixAvation MedicalNoctrix HealthCOUR PharmaceuticalsMMIEpicrispr BiotechnologiesNUCLIDIUMHypervision Surgical

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Angelini Ventures invest in?

Angelini Ventures invests in Biotech and Digital Health at the seed stage.

Which geographies does Angelini Ventures focus on?

Angelini Ventures focuses on Europe, and is headquartered in Italy.

What is Angelini Ventures's typical check size?

Angelini Ventures typically writes checks of $3.9M to $115.5M.

Which startups has Angelini Ventures backed?

Angelini Ventures has 1 tracked investment on Fusion42, including Aptadir Therapeutics.